Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 184 results found. Search for [ Zydus coronavirus vaccine ]

Results 80 to 100 of 184
PB Jayakumar
August 6, 2020
Though margins remain healthy, pricing pressures for the US base generics business, lack of limited competition products and manufacturing quality issues will continue to trouble them, said ICRA


Reuters
August 6, 2020
Last week, Moderna announced the start of a late-stage trial on 30,000 people to demonstrate that its vaccine is safe and effective, the final hurdle prior to regulatory approval


Chitranjan Kumar
August 5, 2020
Share market updates and analysis for August 6: RBI policy announcement, earnings announcements and global cues to set tone for stock markets


BusinessToday.In
August 5, 2020
Coronavirus recovery rate improves to 67.19 per cent, while mortality rate drops to 2.09 per cent. Health ministry says aggressive testing has led to improvement of recovery rate


PB Jayakumar
August 5, 2020
The vaccine, using the platform of plasmid DNA, was found to be safe and well tolerated in the Phase I, which began on 15 July, said Zydus Cadila


BusinessToday.In
August 5, 2020
Coronavirus vaccine news update: The Phase II trial will evaluate the humoral and cellular immune response for the coronavirus vaccine candidate, keeping in line with the current global protocols


Joe C Mathew
August 3, 2020
Indian vaccine manufacturers are waiting for a vaccination plan from the government so that they can set aside stocks of vaccines when they are approved for production


Chitranjan Kumar
July 29, 2020
Share market updates and analysis for July 30: Earnings announcements by Reliance Industries, coronavirus vaccine hopes and US Fed Reserve meeting outcome to set tone for stock markets


PTI
July 28, 2020
Coronavirus vaccine news: Doses of the vaccine were given to 1,077 healthy adults aged between 18 and 55 in five UK hospitals in April and May as part of Phase 1 clinical trial and results, published in The Lancet medical journal


BusinessToday.In
July 25, 2020
Coronavirus vaccine news: Serum Institute of India will start trials of the Oxford University-AstraZeneca COVID-19 vaccine by the end of August. Up to 5,000 Indian volunteers would be included in the tests


BusinessToday.In
July 24, 2020
Coronavirus (Covid-19) Vaccine News Latest Updates:  The study showed that curcumin can prevent Transmissible gastroenteritis virus (TGEV)- an alpha-group coronavirus that infects pigs, from infecting cells. The higher doses of curcumin were also found to kill virus particles


BusinessToday.In
July 23, 2020
Coronavirus (Covid-19) Vaccine News Latest Updates: Head of WHO's emergencies programme Mike Ryan has said that while there are multiple contenders and many companies have made significant progress, the likely time for a coronavirus vaccine in the market is not before 2021


BusinessToday.In
July 22, 2020
Coronavirus (COVID-19) Vaccine News Latest Updates: Dr Cyrus Poonawalla, Chairman of the Poonawalla Group, says a just a few million doses of the potential COVID-19 vaccine will not be enough and the company intends to manufacture around 1 billion doses after getting all the necessary approvals


Chitranjan Kumar
July 21, 2020
Share market updates and analysis for July 22: Corporate earnings announcements, coronavirus vaccine hopes and global cues to set tone for stock markets


BusinessToday.In
July 21, 2020
Vaccine major Serum Institute of India's CEO Adar Poonawalla said on Monday the company will apply for COVID-19 vaccine trials within a week and will soon begin manufacturing the vaccine, developed by Oxford University, in large volumes


BusinessToday.In
July 20, 2020
Hyderabad-based Bharat Bharat Biotech India (BBIL) in collaboration with ICMR's National Institute of Virology (NIV) has developed India's first indigenous COVID-19 vaccine candidate Covaxin


BusinessToday.In
July 20, 2020
Covaxin is being jointly developed by Hyderabad-based Bharat Biotech in collaboration with the Indian Council of Medical Research and the National Institute of Virology and is India's first indigenously developed COVID-19 vaccine candidate


BusinessToday.In
July 19, 2020
Coronavirus vaccine news update: Only 100 participants out of the 375 volunteers would be picked for the first and second phases. The rest would participate in trials at other sites


BusinessToday.In
July 18, 2020
Coronavirus vaccine news update: Goldman Sachs believes that a coronavirus vaccine could be approved by the end of the year. It predicts Moderna and Pfizer's candidates to be the first ones to pass regulatory hurdles


E Kumar Sharma
July 18, 2020
COVAXIN, the country's first possible vaccine against COVID-19, will be tested on 1,125 healthy volunteers in two phases (phase 1 and 2)


PAGES 5 OF 10  12345